To OTC Journal Members:
 

Comments in the BLOG

The only new BLOG entry this week was for BrandPartners (OTC BB: BPTR). The stock's recent rebound phase continues despite the small pullback. Someday BPTR shareholders will be treated to the same kind of ride GEPT shareholders are enjoying right now. I don't know when, but if the company keeps delivering the numbers it is going to happen.

To use the BLOG, simply go to the home page at www.otcjournal.com - the BLOG will scroll down automatically on the right side of your screen. The most current journal entries appear in the middle of your screen. Check back frequently for updates particularly when stocks are moving to overbought or oversold levels or in volatile markets. Your questions and postings do not automatically appear, so don't bother posting the same question multiple times. I personally go through to moderate and respond to every question.
 

Global ePoint (NASDAQ: GEPT); Profit Alert

You are looking at a picture of the OTC Journal's new best friend, Jim Cramer; CNBC show host (Mad Money), columnist, hedge fund manager, and co founder of TheStreet.com. On the CNBC show Mad Money, Cramer jumps around like a maniac, screams, and sweats profusely. People love his antics and listen.

I want to personally thank Mr. Kramer for being the catalyst in this week's breathtaking surge in GEPT.

Since early June I have been encouraging accumulation around the $3 levels. There were two BLOG postings and two full editions.

On Wednesday of this past week GEPT thrilled investors by announcing the introduction of a new technology. The company announced a new video surveillance product for large crowds which was developed from their cockpit video surveillance technology. Not doubt, facial recognition software will be a component in the end product. The introduction was timely in lieu of the recent terrorist events in London, and the market responded by bidding the stock up into the $4 range.

On Thursday evening Jim Cramer included GEPT on his list of "must own" homeland sercurity/defense stocks. Click here to read the news release.

On Friday morning shares of GEPT gapped open and ran to an intraday high of $7 plus. Thank you Mr. Cramer. There was a pretty big short position in this one, and they are getting killed right now.

Here's a weekly chart of the stock going back to the beginning of 2004. The OTC Journal's first edition on the company was November 24, 2004. Since that first edition, the stock has spiked into the $6 range twice, only to be followed by extended pullbacks and lengthy periods of quiet trading activity.

This stock has a history of making short term bursts to the upside, followed by pullbacks. This time the pattern could change. Friday's volume of 15 million shares doubled the best day in the stock's history. There will no be more eyeballs on this stock than ever before.

Nevertheless, my advice would be to take part or all of your profits, with a longer term game plan of buying the stock back after the excitement is over with. At this point I am prepared to guess at about $4.50 to $5 as a good entry level, but let's wait a few weeks and look at Fibonacci retracement levels.

Longer term I believe this could a $10 stock. If you're a seller, you should do so with the idea of recapturing those shares at lower levels. 

This is now the 4th idea I've been able to recommend locking in profits on since June 1. The others include the ZAPZ trade (now ZP), XNOM, and TREN.

This "perfect storm" sequence of events for GEPT shareholders bolsters the concept of accumulating microcaps when they are quiet and no one wants them, and being a seller when the whole world is jumping on the stock. It simply requires a little faith and patience. 

The surge in this stock reinforces my belief that the homeland security/defense sector will enjoy a resurgence of interest later this year. Keep an eye on VTSI and AGSI to benefit when the time comes.

I don't know about you, but this one made my week.

Subscribe

Information is power and timely information is profitable. Become informed and profit from OTC Journal Profiles and Trading Alerts by becoming a Preferred Member today. There is no cost associated with your email subscription. Add your email address below and make sure to check your email inbox and confirm your opt-in request to start receiving the OTC Journal Email Newsletter on a regular basis.

To ensure newsletter delivery, you can add any additional email addresses you may have to the OTC Journal Member List. Receiving the OTC Journal Newsletter in multiple locations is the best way of making sure you don't miss the next investing or trading opportunity! For web based email addresses, the OTC Journal recommends @yahoo.com or @aol.com for timely and reliable email newsletter delivery.

Note: Your email address will be kept strictly confidential, and will not be shared with any other entity for any purpose at any time. If you no longer wish to receive the OTC Journal, simply follow the instructions located at the bottom of every OTC Journal Newsletter Edition.

Go Here to view our compensation on every company we have ever covered, or visit the following web address:  http://www.otcjournal.com/disclaimer.html for our full profiles and http://www.otcjournal.com/trading-alerts/disclaimer.html for Trading Alerts. MarketByte LLC has been paid a fee of $60,000 cash by Global E-Point for coverage of the company. 

All statements and expressions are the sole opinions of the editors and are subject to change without notice. A profile, description, or other mention of a company in the newsletter is neither an offer nor solicitation to buy or sell any securities  mentioned. While we believe all sources of information to be factual and reliable, in no way do we represent or guarantee the accuracy thereof, nor the statements made herein.

From time to time MarketByte LLC sells shares in the open market it receives as compensation for coverage of client companies. Since the shares are received as compensation for services as previously disclosed, and not for investment purposes, the editors do not view the sale of the shares as contradictory to any advice delivered in the content. This should be viewed as a conflict of interest by shareholders or prospective shareholders of the client companies. 

The editor, members of the editor's family, and/or entities with which they are affiliated aside from MarketBtye LLC itself, are forbidden by company policy to own, buy, sell or otherwise trade stock for their own benefit in the companies who appear in the publication unless specifically disclosed in the newsletter. Some of the companies featured in the OTC Journal pay a cash ESP fee to an affiliated technology company ranging from $2,000 to $5,000 per month for internet related technology services. 

The Trustee of the MarketByte LLC Defined Benefit and Trust (“the MarketByte Pension Plan”) has invested approximately $140,0000 in Dutchess Private Equities II LP (“the Dutchess Limited Partnership”), a limited partnership in which the MarketByte Pension Plan is a limited partner.  No one associated with the MarketByte Pension Plan has any knowledge, information, or control as to any past, present, or future investment activities of the Dutchess Limited Partnership.  The Dutchess Limited Partnership is one of two hedge funds managed by Dutchess Advisors.  Dutchess Advisors periodically refers companies to MarketByte LLC for possible coverage by one of the MarketByte LLC publications, which publications include The OTCJournal.com Newsletter.  Dutchess Advisors may or may not own shares in the companies that it so refers to MarketByte.  MarketByte has no information (outside of information readily accessible to the general public such as SEC filings) as to whether Dutchess Advisors owns any shares in the companies that it refers to MarketByte LLC.  The above relationships should be viewed as a potential and/or actual conflict of interest by shareholders and prospective shareholders of MarketByte LLC client companies.

The profiles, critiques, and other editorial content of the OTCjournal.com may contain statements that appear foward relating to the expected capabilities of the companies mentioned herein.

THE READER SHOULD VERIFY ALL CLAIMS AND DO THEIR OWN DUE DILIGENCE BEFORE INVESTING IN ANY SECURITIES MENTIONED. INVESTING IN  SECURITIES IS SPECULATIVE AND CARRIES A HIGH DEGREE OF RISK. THE INFORMATION FOUND IN THIS PROFILE IS PROTECTED BY THE COPYRIGHT LAWS OF THE UNITED STATES AND MAY NOT BE COPIED, OR REPRODUCED IN ANY WAY WITHOUT THE EXPRESSED, WRITTEN  CONSENT OF THE EDITORS OF OTCjournal.com.

We encourage our readers to invest carefully and read the investor information available at the web sites of  the Securities and Exchange Commission ("SEC") at http://www.sec.govand/or the National Association of Securities Dealers ("NASD") at http://www.nasd.com. We also strongly recommend that you read the SEC advisory to investors concerning Internet Stock Fraud, which can be found at  http://www.sec.gov/consumer/cyberfr.htm. Disclaimer ID:$subst('Recip.userid') Readers can review all public filings by companies at the SEC's EDGAR page. The NASD has published information on how to invest carefully at its web site.  MarketByte LLC's mailing address is 3525 Del Mar Heights Rd #334, San Diego, CA 92130.